BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com
Equities research analysts at StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a research note issued on Wednesday. The firm set a “sell” rating on the medical technology company’s stock. BIOLASE Price Performance BIOL stock opened at $0.01 on Wednesday. The firm has a fifty day moving average price of […]
Equities research analysts at StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a research note issued on Wednesday. The firm set a “sell” rating on the medical technology company’s stock. BIOLASE Price Performance BIOL stock opened at $0.01 on Wednesday. The firm has a fifty day moving average price of […]
